Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Zolis_onkel's Profile
Displaying 51-100 of 575 result(s).
GNBTQ Generex Biotechnology Corp.
01/19/2022 10:29:39 AM
I keep wondering how "you folks" ca (3)
GNBTQ Generex Biotechnology Corp.
01/11/2022 9:58:52 AM
This is still much too negative in (4)
GNBTQ Generex Biotechnology Corp.
01/10/2022 6:06:07 PM
I Cent dispute, and - if you read m (1)
GNBTQ Generex Biotechnology Corp.
01/10/2022 6:01:57 PM
Well, thanks a lot, for tearing my (3)
GNBTQ Generex Biotechnology Corp.
01/10/2022 3:49:56 PM
I can hardly imagine any rational t (3)
GNBTQ Generex Biotechnology Corp.
01/10/2022 12:58:57 AM
As Southbill also pointed out the c (4)
GNBTQ Generex Biotechnology Corp.
01/09/2022 4:13:51 PM
In regards to Theranos have you see (1)
GNBTQ Generex Biotechnology Corp.
01/09/2022 2:19:40 AM
I don't believe this to be true. Ca
GNBTQ Generex Biotechnology Corp.
01/03/2022 5:56:59 PM
And in turn this could provide the (1)
GNBTQ Generex Biotechnology Corp.
12/29/2021 7:38:04 AM
Hi Cody, Thanks a lot for your reas (6)
GNBTQ Generex Biotechnology Corp.
12/29/2021 2:27:23 AM
This is poking in the dark and assu
GNBTQ Generex Biotechnology Corp.
12/28/2021 1:38:48 PM
I have just tried to offer a possib
GNBTQ Generex Biotechnology Corp.
12/28/2021 1:09:19 PM
I don't know the answers to these q
GNBTQ Generex Biotechnology Corp.
12/28/2021 11:49:22 AM
I am not kidding, I am just not tun (4)
GNBTQ Generex Biotechnology Corp.
12/28/2021 11:34:34 AM
Joe remained silent for almost 18 m (5)
GNBTQ Generex Biotechnology Corp.
12/28/2021 10:53:29 AM
In reply to your post, let me ask y (2)
GNBTQ Generex Biotechnology Corp.
12/24/2021 4:05:52 PM
Sure, I have thought about that, an (1)
GNBTQ Generex Biotechnology Corp.
12/24/2021 2:46:33 PM
Death spiral is all about diluting (2)
GNBTQ Generex Biotechnology Corp.
12/24/2021 10:56:52 AM
Well, I have not picked up the phon (1)
GNBTQ Generex Biotechnology Corp.
12/24/2021 9:31:12 AM
So what is your source of informati (5)
GNBTQ Generex Biotechnology Corp.
12/23/2021 6:10:40 PM
Come on, drexel, your know well eno (6)
GNBTQ Generex Biotechnology Corp.
12/21/2021 5:51:51 AM
There are a whole bunch of possible (2)
GNBTQ Generex Biotechnology Corp.
12/21/2021 2:41:07 AM
Hylander, I think I wrote about thi (3)
GNBTQ Generex Biotechnology Corp.
12/17/2021 9:12:27 AM
Hey doc, it currently seems as if w (2)
GNBTQ Generex Biotechnology Corp.
12/17/2021 7:25:34 AM
"Hilarious. You and good4nthing nee (2)
GNBTQ Generex Biotechnology Corp.
12/10/2021 8:39:35 AM
Of course, this is possible, but in (5)
GNBTQ Generex Biotechnology Corp.
12/10/2021 1:12:11 AM
So first of all, thanks a lot Docj, (10)
GNBTQ Generex Biotechnology Corp.
11/30/2021 1:11:18 AM
Well, I am for sure no mind reader, (4)
GNBTQ Generex Biotechnology Corp.
11/29/2021 4:58:26 PM
... or yet another frustrated and d
GNBTQ Generex Biotechnology Corp.
11/29/2021 2:15:58 PM
I bought some more today (prior to (1)
GNBTQ Generex Biotechnology Corp.
11/23/2021 5:18:11 PM
Because they had to announce a dela (1)
GNBTQ Generex Biotechnology Corp.
11/23/2021 3:38:51 PM
I respectfully disagree with the st (2)
GNBTQ Generex Biotechnology Corp.
11/20/2021 4:06:39 AM
Ok, everyone, let's be very conserv (4)
GNBTQ Generex Biotechnology Corp.
11/18/2021 10:10:08 AM
I do, as we know very little more t (2)
GNBTQ Generex Biotechnology Corp.
11/18/2021 9:25:27 AM
But Colonel Jassip admitted that he (2)
GNBTQ Generex Biotechnology Corp.
11/17/2021 12:04:55 PM
They are not worthless free shares! (1)
GNBTQ Generex Biotechnology Corp.
11/17/2021 12:02:25 PM
To be honest, they only selectively
GNBTQ Generex Biotechnology Corp.
11/15/2021 1:46:39 PM
If my assumption is true that the c
GNBTQ Generex Biotechnology Corp.
11/15/2021 12:02:21 PM
... this is like in midieval times,
GNBTQ Generex Biotechnology Corp.
11/15/2021 11:53:11 AM
Uncertainty is always bad for inves (1)
GNBTQ Generex Biotechnology Corp.
11/15/2021 11:17:05 AM
What is the expression opposite to
GNBTQ Generex Biotechnology Corp.
11/09/2021 11:40:36 AM
I did so, too, yesterday, Cody! Ano
GNBTQ Generex Biotechnology Corp.
11/08/2021 12:43:56 PM
Hey spinner, (by the way, your nick (4)
GNBTQ Generex Biotechnology Corp.
11/08/2021 11:32:37 AM
Hey Doc, here is my answer to your (4)
GNBTQ Generex Biotechnology Corp.
11/04/2021 2:11:41 PM
Oh, wow, all my best wishes for him (1)
GNBTQ Generex Biotechnology Corp.
11/01/2021 10:53:09 AM
Again, Hylander, you make the mista (2)
GNBTQ Generex Biotechnology Corp.
10/27/2021 9:33:14 AM
Thanks, Buildit, both for your lett (5)
GNBTQ Generex Biotechnology Corp.
10/22/2021 12:33:43 PM
There is a significant difference b (2)
GNBTQ Generex Biotechnology Corp.
10/22/2021 11:37:08 AM
Hylander, I hear you, and believe i (7)
GNBTQ Generex Biotechnology Corp.
10/20/2021 11:34:44 AM
TRUE!! You are absolutely right in (1)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch benzingaheadline@gmail.com. Target readers who trust our platform to stay ahead of the curve.

Recent Articles

  • Electra Welcomes Admiral Hueber to Strengthen Board Leadership
  • Aclaris Therapeutics Shares Promising Data on ATI-2138 Advances
  • Five-Year Follow-Up Shows Improved Survival in NSCLC Patients
  • Pet Valu Unveils Innovative Distribution Centre in Calgary
  • Mobilicom's U.S. Drone Orders Surge to $1.55 Million
  • Sight Sciences' OMNI System Gains Improved Coverage with UHC
  • Brown & Brown, Inc. Celebrated Again as a Top Workplace in Finance
  • Octopus AIM VCT 2 plc Reports Growth in Net Asset Value
  • Octopus AIM VCT plc Reports Current Net Asset Value Insights
  • Appili Therapeutics Strengthens Biodefense with ATI-1701 Vaccine
  • Advancements in Tularemia Vaccine Research by Appili Therapeutics
  • ChitogenX Explores Strategic Merger with Oligo Medic Inc.
  • Community Engagement: The Key to Lopez Automotive's Success
  • Lockheed Martin and BAE Systems Collaborate on UAV Innovations
  • Empowering Leadership: Join the LEAD3R Accelerator Experience
  • Employers Embrace Transparency to Manage Healthcare Costs Effectively
  • NS-229 Receives FDA Fast Track Status for Rare Disease Treatment
  • Tongji University's Remarkable Rise in Global Management Rankings
  • RingConn Unveils Groundbreaking Blood Pressure Monitoring Feature
  • Harness Reaches New Heights: Celebrating Innovative Workplaces
  • Insights into Holiday Retail Trends and Consumer Behavior
  • Sapiens Introduces Enhanced CoreSuite for the Insurance Industry
  • Exciting Innovations Unveiled at HR Tech 2025 Next Week
  • Serve Robotics Expands Capabilities with Voysys Acquisition
  • Accrual Equity Partners Welcomes JT Taylor as Managing Partner
  • Celebrating Two Decades of Ubiquitin Discoveries and Advances
  • Harvard Bioscience Welcomes New Board Member Stephen DeNelsky
  • Plug Power's Prominence Shines at HC Wainwright Conference
  • McDermott Wins Subsea Contract for Block H Gas Field in Malaysia
  • Collaboration of SOLVEAT and CBC to Craft Innovative Beverages
  • Electra Battery Materials Welcomes Admiral Hueber to Board
  • Aclaris Therapeutics Shares Promising Updates from EADV Congress
  • Cenovus Energy Finalizes Sale of WRB Refining Interest
  • Reitar Logtech Ventures into Strategic Partnership with Solowin
  • Bitget Introduces Switchboard (SWTCH) to Its Launchpool
  • CI Global Asset Management to Acquire Forge First Asset Management
  • easyGroup Introduces User-Friendly Bitcoin Investment App
  • Potential for Tech Stock Growth Amidst Low Recession Fears
  • Ardent Mills' Latest ESG Report Highlights Sustainability and Progress
  • Transforming Daily Spending into Housing Savings for Canadians
  • Intellum Revolutionizes Learning with New Evolve Authoring Tool
  • Corero Network Security Unveils Adaptive DDoS Strategies
  • Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth
  • Barlow Metal Unveils Strong Economic Assessment for Iron Hills
  • Reitar Logtech and Solowin Holdings: A Pioneering Partnership
  • FDA Approves AB001: A Breakthrough in Prostate Cancer Therapy
  • Designer Brands Inc. Releases Strong Q2 2025 Financial Performance
  • Tagworks Pharmaceuticals Progresses with TGW101 Phase 1 Trial
  • Corero Network Security Enhances DDoS Protection Accessibility
  • Health Canada Greenlights Bylvayâ„¢ for Alagille Syndrome Relief
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site